Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | DRD2 | P14416 | 4/20 | 0.47 |
| ▸ | DRD3 | P35462 | 4/20 | 0.47 |
| ▸ | DRD4 | P21917 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | G6PD | P11413 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31172547 | 0.84 | NPC1 (0.47) | NPC1MAPK1DRD2DRD3DRD4 | |
| SCHEMBL29186553 | 0.83 | KDM4E (0.47) | NPC1MAPK1DRD2DRD3DRD4 | |
| SCHEMBL8145577 | 0.82 | NTRK1 (0.49) | MAPK1DRD2DRD3DRD4MAPT | |
| SCHEMBL14542966 | 0.81 | MAPK1 (0.51) | NPC1MAPK1DRD2DRD3DRD4 | |
| SCHEMBL20897188 | 0.81 | ALDH1A1 (0.49) | NPC1MAPK1DRD2DRD3DRD4 | |
| SCHEMBL14951066 | 0.80 | KMT2A (0.55) | DRD2DRD3DRD4MAPTMEN1 | |
| SCHEMBL7033553 | 0.80 | HCRTR1 (0.45) | NPC1MAPK1DRD2DRD3DRD4 | |
| SCHEMBL4341886 | 0.80 | MAPK1 (0.67) | NPC1MAPK1DRD2DRD3DRD4 | |
| SCHEMBL31589183 | 0.79 | KDM4E (0.42) | NPC1MAPK1DRD2DRD3DRD4 | |
| SCHEMBL9048500 | 0.79 | NPC1 (0.43) | NPC1MAPK1DRD2DRD3DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534437-B2 | Photoredox-catalyzed direct C—H functionalization of arenes | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2026-01-27 | — | — | US | disclosed |
| US-20250059204-A1 | FUSED BENZOISOXAZOLYL COMPOUNDS AS KAT6A INHIBITORS | AURIGENE ONCOLOGY LIMITED (IN) | 2025-02-20 | — | — | US | disclosed |
| CN-113226321-B | Pyrazolyl compounds and methods of use thereof | 阿利安制药有限责任公司 | 2024-12-17 | — | — | CN | disclosed |
| EP-4448109-A1 | FUSED BENZOISOXAZOLYL COMPOUNDS AS KAT6A INHIBITORS | Aurigene Oncology Limited (IN) | 2024-10-23 | — | — | EP | disclosed |
| WO-2023114710-A1 | FUSED BENZOISOXAZOLYL COMPOUNDS AS KAT6A INHIBITORS | AURIGENE ONCOLOGY LIMITED (IN) | 2023-06-22 | — | — | WO | disclosed |
| US-20230167067-A1 | PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES | UNIV NORTH CAROLINA CHAPEL HILL (US) | 2023-06-01 | — | — | US | disclosed |
| US-20230167067-A1 | PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES | UNIV NORTH CAROLINA CHAPEL HILL (US) | 2023-06-01 | — | — | US | disclosed |
| US-20230167067-A1 | PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES | UNIV NORTH CAROLINA CHAPEL HILL (US) | 2023-06-01 | — | — | US | disclosed |
| US-11584720-B2 | Photoredox-catalyzed direct C-H functionalization of arenes | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2023-02-21 | — | — | US | disclosed |
| US-11584720-B2 | Photoredox-catalyzed direct C-H functionalization of arenes | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2023-02-21 | — | — | US | disclosed |
| US-20150209301-A1 | PATCH FOR ANTI-DERMATOPHYTOSIS | NICHIBAN COMPANY LIMITED (JP) | 2015-07-30 | — | — | US | disclosed |
| EP-2889031-A1 | ANTITRICHOPHYTOSIS SOLUTION FOR EXTERNAL USE | Meiji Seika Pharma Co., Ltd. (JP) | 2015-07-01 | — | — | EP | disclosed |
| EP-2881114-A1 | ANTI-TRICHOPHYTIC ADHESIVE PATCH | Meiji Seika Pharma Co., Ltd. (JP) | 2015-06-10 | — | — | EP | disclosed |
| CN-104661661-A | External liquid preparation for resisting trichophytosis | MEIJI SEIKA PHARMA CO LTD | 2015-05-27 | — | — | CN | disclosed |
| WO-2014164767-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FORMA THERAPEUTICS, INC. (US) | 2014-10-09 | — | — | WO | disclosed |
| WO-2014164749-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FORMA THERAPEUTICS, INC. (US) | 2014-10-09 | — | — | WO | disclosed |
| US-20140030209-A1 | TOPICAL LIQUID AGENT FOR THE TREATMENT OF DERMATOPHYTOSIS | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2014-01-30 | — | — | US | disclosed |
| EP-1313733-A1 | PYRAZOLOPYRIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-05-28 | — | — | EP | disclosed |
| WO-2002018382-A1 | PYRAZOLOPYRIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-03-07 | — | — | WO | disclosed |
| US-3979141-A | Pressure-sensitive recording system comprising 3'-amino-6' or 7'-(pyrazol-1-yl)fluoran compounds as color precursors | MOORE BUSINESS FORMS, INC. (US) | 1976-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11584720-B2 | Photoredox-catalyzed direct C-H functionalization of arenes | PPOX, AOC2, AOC3 | NPC1 1847/4885MAPK1 3425/4885DRD2 165/4885 |
| US-12534437-B2 | Photoredox-catalyzed direct C—H functionalization of arenes | PF4, PPOX, AOC2 | NPC1 2056/4885MAPK1 3813/4885DRD2 131/4885 |
| US-20250059204-A1 | FUSED BENZOISOXAZOLYL COMPOUNDS AS KAT6A INHIBITORS | KAT6A, KAT2A, KAT6B | NPC1 567/4885MAPK1 1559/4885DRD2 4692/4885 |
| US-20140030209-A1 | TOPICAL LIQUID AGENT FOR THE TREATMENT OF DERMATOPHYTOSIS | POLR1C, CUTA, C1R | NPC1 330/4885MAPK1 2683/4885DRD2 863/4885 |
| US-20150209301-A1 | PATCH FOR ANTI-DERMATOPHYTOSIS | CUTA, NACA, POLR1C | NPC1 1806/4885MAPK1 1099/4885DRD2 624/4885 |
| US-20230167067-A1 | PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES | PPOX, AOC2, AOC3 | NPC1 1847/4885MAPK1 3425/4885DRD2 165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.